Literature DB >> 18579550

Whole-body resting and exercise-induced lipolysis in sarcopenic [corrected] patients with COPD.

F M E Franssen1, H P Sauerwein, E P A Rutten, E F M Wouters, A M W J Schols.   

Abstract

Impaired beta-adrenoceptor-mediated lipolysis has been reported in sarcopenic [corrected] chronic obstructive pulmonary disease (COPD) patients. This could play a role in the shift in body composition towards decreased fat-free mass (FFM) and relative maintenance of fat mass (FM). Lipolysis could be affected by chronic treatment with beta(2)-agonists or disease-related factors. Therefore, whole-body resting and exercise-induced lipolysis were investigated in sarcopenic [corrected] COPD patients with moderate disease severity. Seven sarcopenic [corrected] COPD patients (mean+/-sem forced expiratory volume in one second (FEV(1)) 53+/-5% of the predicted value; body mass index (BMI) 27.5+/-0.9 kg x m(-2)) and seven controls matched for age, sex and BMI were studied. In addition, six underweight COPD patients (FEV(1) 51+/-5% pred; BMI 20.6+/-0.7 kg x m(-2)) matched for disease severity were recruited. Lipolysis and plasma levels of catecholamines were assessed during infusion of [(2)H(5)]glycerol at rest and during submaximal cycling exercise. The proportional FM was comparable between sarcopenic [corrected] patients and controls, whereas the FFM index was significantly reduced in patients. At rest, the rate of appearance (R(a)) of glycerol (4.1+/-0.6 and 3.3+/-0.2 micromol x kg FFM(-1) x min(-1), respectively) did not differ significantly. In underweight patients, glycerol R(a) (4.3+/-0.5 micromol x kg FFM(-1) x min(-1)) was also comparable. End-of-exercise lipolytic rates did not differ significantly between groups. Glycerol R(a) was not related to FM. Resting adrenalin levels were significantly increased in underweight COPD patients and were related to resting lipolysis. Sarcopenia [corrected] in chronic obstructive pulmonary disease patients with moderate disease severity is not characterised by an abnormal lipolytic rate. Altered regulation of muscle protein turnover seems to be the trigger in the body compositional shift observed in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579550     DOI: 10.1183/09031936.00014008

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  3 in total

1.  Body composition and sarcopenia in patients with chronic obstructive pulmonary disease.

Authors:  Tatiana Munhoz da Rocha Lemos Costa; Fabio Marcelo Costa; Thaísa Hoffman Jonasson; Carolina Aguiar Moreira; César Luiz Boguszewski; Victória Zeghbi Cochenski Borba
Journal:  Endocrine       Date:  2018-02-05       Impact factor: 3.633

2.  Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease.

Authors:  Christina C Kao; Jean W-C Hsu; Venkata Bandi; Nicola A Hanania; Farrah Kheradmand; Farook Jahoor
Journal:  J Appl Physiol (1985)       Date:  2011-10-20

3.  Sarcopenia in COPD: relationship with COPD severity and prognosis.

Authors:  Tatiana Munhoz da Rocha Lemos Costa; Fabio Marcelo Costa; Carolina Aguiar Moreira; Leda Maria Rabelo; César Luiz Boguszewski; Victória Zeghbi Cochenski Borba
Journal:  J Bras Pneumol       Date:  2015 Sep-Oct       Impact factor: 2.624

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.